In AD, BECN1 deficiency accelerates Aβ and tau accumulation, while the BECN1 F121A mutation enhances autophagy and therefore reduces Aβ plaques and improves cognition in mouse models. The gene discussed is MAPT; the disease is Alzheimer disease.